7 resultat
GOVERNMENT INTERESTS
Not applicable
PARTIES TO A JOINT RESEARCH AGREEMENT
Not applicable
INCORPORATION BY REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not applicable
BACKGROUND
Not applicable
BRIEF SUMMARY OF THE INVENTION
Embodiments of the present invention relate generally to compositions
GOVERNMENT INTERESTS
Not applicable
PARTIES TO A JOINT RESEARCH AGREEMENT
Not applicable
INCORPORATION BY REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not applicable
BACKGROUND
Not applicable
BRIEF SUMMARY OF THE INVENTION
Embodiments of the present invention relate generally to compositions
BACKGROUND OF THE INVENTION
Acne is a condition of the human skin characterized by an excess flow of sebum, or skin oil, from the sebaceous glands located in the pilosebaceious apparatus. Sebum reaches the skin surface through the duct of the hair follicle. The presence of excessive amounts of sebum
BACKGROUND OF THE INVENTION
The present invention is directed to improved methods of treating inflammatory skin disease.
Inflammatory skin disease, particularly chronic inflammatory skin disease, is still a major source of morbidity. Such inflammatory skin diseases are disfiguring and cause severe
BACKGROUND OF THE INVENTION
The present invention is directed to improved methods of treating inflammatory skin disease.
Inflammatory skin disease, particularly chronic inflammatory skin disease, is still a major source of morbidity. Such inflammatory skin diseases are disfiguring and cause severe
TECHNICAL FIELD
The present invention, in some embodiments thereof, relates to health and natural products. Specifically it relates to products to improve the structure and function of diseased articulations (joints) of the body by alleviating articular (joint) pain, inflammation and
TECHNICAL FIELD OF THE INVENTION
The present invention relates generally to a skin blemish treatment and more specifically to a formulation that contains carbamide peroxide and one or more alpha-hydroxy acids. This formulation proves effective without the toxic effects of formulations containing